- Message from Cancerkin’s Founder and President, Santy Parbhoo
- Can Roses Help Prevent Breast Cancer Aggressiveness?
Message from Cancerkin’s Founder and President, Santy Parbhoo
Dear Friend, Supporter or Patient,
I am unable to join in this year’s walk as I shall be away. Last year with your help I was sponsored to a total of £10,000. Your help aids us enormously to continue our work particularly in the Cancerkin Lymphoedema Clinic which treats patients from all over Greater London. Victoria Todd – our CEO and her team have worked hard and have successfully obtained major funds from Grant giving bodies including the National Lottery. With the merger of Barnet & Chase Farm Hospitals, which have substantial Breast Units, with the Royal Free NHS Trust our services will be required even more.
In my absence, I hope you will give Victoria generous support so that the Cancerkin 2015 Walk target of £50,000 will be reached.
For those of you who are doing the Walk – my sincere apologies. I do enjoy meeting you all – but that will have to wait until next year or at our next Event.
Very many thanks for your help and continuing support.
Santy Parbhoo Founder & President of Cancerkin
Study findings suggest roses may help to reduce the spread of triple negative breast cancer A recent study has shown that using extracts from rosehips, the fruit plant of roses, can help to reduce the spread of triple negative breast cancer – a subtype of breast cancer that accounts for 10 – 20% of breast cancer cases. The term “triple negative” refers to the unique characteristics of this subtype, in that these particular malignant cells lack three key receptors – oestrogen, progesterone and human growth factor 2 – that are targeted in standard breast cancer treatment. As a result, there are fewer options to combat the disease effectively.
The study involved treating tissue samples of triple negative breast cancer cells with various concentrations of rosehip – a natural source of vitamin C used in tea and other foods – with the result that the rate of breast cancer cell growth was observed to decrease by half at the highest concentration. Further experiments have suggested possible mechanisms behind these results. Rosehip extract may inhibit the function of two key enzymes involved in triple negative breast cancer cell growth and notably the extract was found to improve the effectiveness of the chemotherapy drug doxorubicin.
Dr Martin, the principal study investigator, commented on these findings saying with further study it is hoped rosehip may be used as a preventative strategy in breast cancer or as a combination in standard cancer therapy in the future.